XML 39 R15.htm IDEA: XBRL DOCUMENT

Concentrations	3 Months Ended
Concentrations	Mar. 31, 2015
Risks And Uncertainties [Abstract]
Concentrations	(9) CONCENTRATIONS The Company sourced approximately 40% and 19% of components for its electrotherapy products from one vendor during the three months ended March 31, 2015 and 2014, respectively. Management believes that its relationships with suppliers are good; however, the Company has delayed and extended payments to many of its vendors for cash flow reasons, which has caused many of its vendors to require pre-payment for products or services. If the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred. The Company had receivables from a private health insurance carrier at March 31, 2015 and December 31, 2014, that made up approximately 5% and 10%, respectively, of the net accounts receivable balance.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References+ Details